Concepedia

Ashlee V. Moses

AV

44

Publications

4.9K

Citations

32

H-Index

1990

Active since

Affiliations

Oregon Health & Science University(Current)

Children's Cancer Therapy Development Institute

Harvard University

University of Washington

Vaccine and Gene Therapy Institute

Ashlee V. Moses is an author at Oregon Health & Science University specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

1990–2018

44

Publications

44

Fractalkine Preferentially Mediates Arrest and Migration of CD16+ Monocytes

Petronela Ancuța, Ravi Rao, Ashlee V. Moses et al. · The Journal of Experimental Medicine · 2003 · 564 citations · Full text

Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood–brain barrier model for drug permeability studies

Daniela Elisabeth Eigenmann, Gongda Xue, Kwang S. Kim et al. · Fluids and Barriers of the CNS · 2013 · 407 citations · Full text

Blood-Brain Barrier Tight Junction Disruption in Human Immunodeficiency Virus-1 Encephalitis

Linda M. Dallasta, Liubomir A. Pisarov, James E. Esplen et al. · American Journal Of Pathology · 1999 · 370 citations · Full text

, , +8

Vpu Directs the Degradation of the Human Immunodeficiency Virus Restriction Factor BST-2/Tetherin via a βTrCP-Dependent Mechanism

Janet L. Douglas, Kasinath Viswanathan, Matthew N. McCarroll et al. · Journal of Virology · 2009 · 333 citations · Full text

IRF-3, IRF-5, and IRF-7 Coordinately Regulate the Type I IFN Response in Myeloid Dendritic Cells Downstream of MAVS Signaling

Helen M. Lazear, Alissa M. Lancaster, Courtney Wilkins et al. · PLoS Pathogens · 2013 · 293 citations · Full text

Rows per page

1–5 of 44